Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation
Winde, G.; Dietl, K.H.; Raidt, H.; Buchholz, B.; Lison, A.E.; Bünte, H.
Transplantation Proceedings 20(5 Suppl 6: 87-89
1988
ISSN/ISBN: 0041-1345 PMID: 3140453 Document Number: 314172
Document emailed within 1 workday
Related Documents
Palmer, J.; Slook, P. 1992: Successful use of Orthoclone OKT 3 for steroid-resistant acute rejection in pediatric renal allograft recipients Anna Journal 19(4): 375-377Xiao, X.; Li, Y.; Cheng, Y.; Ao, J. 1992: Urinary active T-rosette-forming cells in the diagnosis of acute allograft rejection after cadaveric kidney transplantation Transplantation Proceedings 24(4): 1545-1546
Abouna, G.M.; Kumar, M.S.; Stephan, R.; Prior, J.E.; Lyons, P.; Bulova, S.I.; al-Abdullah, I.H. 1993: Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation Transplantation Proceedings 25(3): 2241-2242
Isoniemi, H.; Kyllönen, L.; Eklund, B.; Höckerstedt, K.; Salmela, K.; von Willebrand, E.; Ahonen, J. 1995: Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss Transplantation Proceedings 27(1): 875-877
d'Apice, A.J.; Thurlow, P.J.; Ihle, B.U.; Lovering, E.K.; McKenzie, I.F. 1987: Treatment of acute renal allograft rejection with a monoclonal antibody to a T cell antigen (HuLy-m2) Australian and New Zealand Journal of Medicine 17(2): 210-215
Kountz, S.L.; Rao, T.K.; Butt, K.H. 1975: The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection Transplantation Proceedings 7(1): 73-77
Nickel, P.; Lacha, J.; Ode-Hakim, S.; Sawitzki, B.; Babel, N.; Frei, U.; Volk, H.D.; Reinke, P. 2001: Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft Transplantation 72(6): 1158-1160
Woodle, E.S.; Xu, D.; Zivin, R.A.; Auger, J.; Charette, J.; O'Laughlin, R.; Peace, D.; Jollife, L.K.; Haverty, T.; Bluestone, J.A.; Thistlethwaite, J.R. 1999: Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection Transplantation 68(5): 608-616
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Jordan, S.C.; Quartel, A.W.; Czer, L.S.; Admon, D.; Chen, G.; Fishbein, M.C.; Schwieger, J.; Steiner, R.W.; Davis, C.; Tyan, D.B. 1998: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66(6): 800-805
Seydoux, C.; Gillard Berguer, D.; Wauters, J.P.; Mosimann, F.; Stumpe, F.; Hurni, M.; Ruchat, P.; Aubert, V.; Sadeghi, H.; Goy, J.J. 1996: Heart-kidney transplantation of the same donor following failure of a first renal transplantation due to chronic rejection Schweizerische Medizinische Wochenschrift 126(50): 2181-2183
Simić-Ogrizović, S.; Djukanović, L.; Golubović, M.; DimitrijevićZ; Mimić-Oka, J.; Simić, T. 1994: Significance of laboratory tests for differential diagnosis of acute renal allograft rejection and acute cyclosporine nephrotoxicity Srpski Arhiv Za Celokupno Lekarstvo 122(5-6): 133-136
Zhang, A-bin.; Zheng, S-sen.; Jia, C-ku.; Wang, Y. 2004: Role of 1,25-dihydroxyvitamin D3 in preventing acute rejection of allograft following rat orthotopic liver transplantation Chinese Medical Journal 117(3): 408-412
Sakurai, M.; Fukuyama, N.; Iguchi, A.; Akimoto, H.; Ohmi, M.; Yokoyama, H.; Nakazawa, H.; Tabayashi, K. 1999: Quantitative analysis of cardiac 3-L-nitrotyrosine during acute allograft rejection in an experimental heart transplantation Transplantation 68(11): 1818-1822
Taber, S. 1982: Renal replacement therapy. 6-2 other aspects of renal transplantation-donor procurement, preservation and alternative rejection therapy Nursing Times 78(22): 935-939
Kłoda, K.; Domanski, L.; Pawlik, A.; Kurzawski, M.; Safranow, K.; Ciechanowski, K. 2010: Effect of the ICAM1 and VCAM1 gene polymorphisms on delayed graft function and acute kidney allograft rejection Annals of Transplantation 15(4): 15-20
Vanikar, A.V.; Trivedi, H.; Patel, R.D.; Kanodia, K.V.; Trivedi, V.B.; Shah, P.R.; Gupta, S.B.; Dabhi, M.; Gumber, M.; Goplani, K. 2007: Diagnosis of acute humoral rejection using immunofluorescence in renal allograft biopsies- one step towards better understanding! Indian Journal of Pathology and Microbiology 50(3): 502-506
Troncoso, P.; Stepkowski, S.M.; Wang, M.E.; Qu, X.; Chueh, S.C.; Clark, J.; Kahan, B.D. 1999: Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine Transplantation 67(1): 145-151
Mangino, M.J.; Brunt, E.M.; Von Doersten, P.; Anderson, C.B. 1989: Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection Journal of Pharmacology and Experimental Therapeutics 248(1): 23-28
Williamson, E.P.; Millar, R.J.; Criddle, R.A.; Sells, R.A. 1987: The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology Transplantation Proceedings 19(1 Part 2): 1785-1786